AzTrials
AzTrials

Post-COVID-19 SyndromeNCT05765591

Balneotherapy for Patients With Post-acute Coronavirus Disease (COVID) Syndrome

A study testing Balneotherapy and aquatic exercises in people with Post-COVID-19 Syndrome, run by Parc de Salut Mar at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this randomized controlled study is to evaluate the effects of balneotherapy (BT) and aquatic exercises in patients with post-acute COVID syndrome (PACS). The main question it aims to answer are: Does BT and aquatic exercises alleviate some of the most prevalent features that characterize post-acute COVID… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Post-COVID-19 Syndrome
What is being tested?
Balneotherapy and aquatic exercises
Could I receive a placebo?
No, everyone receives an active treatment
How many people
98 participants
Where
1 siteSpain
Study dates
29 Mar 2022to 31 Jan 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Individuals ≥18 years old with a post-acute COVID-19 syndrome diagnosis provided by a physician.

Who cannot join

  • Patients with preexisting disorders to the acute SARS-CoV-2 infection that displayed an important clinical overlap with PACS i.e., fibromyalgia (FM), chronic fatigue syndrome, chronic pain, and generalized anxiety disorder and/or depression that required pharmacological treatment. Patients with chronic debilitating conditions that required active treatment were also excluded i.e. cancer, chronic viral infections, systemic autoimmune diseases, epilepsy, uncontrolled endocrine disorders, etc. Patients with fear of water, incontinence, severe venous insufficiency, physical disabilities that hindered performance of balneotherapy/aquatic exercises, and those who reported a tendency for symptomatic low blood pressure were also excluded.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Hospital del Mar Medical Research Institute

    Barcelona, 08003

Other trials in Spain

About this study

Official title: Effects of Balneotherapy for Patients With Post-COVID Syndrome

The goal of this randomized controlled study is to evaluate the effects of balneotherapy (BT) and aquatic exercises in patients with post-acute COVID syndrome (PACS). The main question it aims to answer are:

  • Does BT and aquatic exercises alleviate some of the most prevalent features that characterize post-acute COVID syndrome?
Read more

Participants allocated to the intervention group will undergo 3 weekly sessions of BT and aquatic exercises on alternate days in groups of 8 during 4 weeks. Prior the beginning of the intervention, patients were asked to complete an array of validated self-reported questionnaires that covered an important part of PACS symptomatology. These patients were asked to complete these same questionnaires immediately after completing the intervention and one month after. They were also asked to report adverse events associated to the intervention.

Patients allocated to the control group were asked to complete the same questionnaires at baseline and one and two months post-baseline. They were instructed to not enroll in any kind of BT-related activities during the duration of the study.

Questionnaires were analyzed and compared between groups to assess the effects of the intervention.

Read the detailed description

Participants were recruited in the multidisciplinary Post-COVID unit of the Hospital del Mar or in a primary care center in Barcelona (Spain). In addition, Caldes de Montbui's City Council also advertised the project for patient recruitment on its public website. Inclusion criteria were individuals ≥18 years old with a PACS diagnosis provided by a physician.

Exclusion criteria included patients with preexisting disorders to the severe acute respiratory syndrome (SARS) coronavirus (CoV) 2 infection that displayed an important clinical overlap with PACS i.e., fibromyalgia (FM), chronic fatigue syndrome, chronic pain, and generalized anxiety disorder and/or depression that required pharmacological treatment. Patients with chronic debilitating conditions that required active treatment were also excluded i.e. cancer, chronic viral infections, systemic autoimmune diseases, epilepsy, uncontrolled endocrine disorders, etc. Patients with fear of water, incontinence, severe venous insufficiency, physical disabilities that hindered performance of Balneotherapy (BT)/aquatic exercises, and those who reported a tendency for symptomatic low blood pressure were also excluded. Blood tests performed within 4 months or less before the initial visit were mandatory for preselection and were reviewed: patients with anaemia, chronic kidney disease (CKD) stage 4 or less, chronic liver insufficiency, thyroid function abnormalities, and in general, any significant blood test abnormality that could be associated with PACS-related symptomatology were excluded.

Included patients underwent initial visit in which clinical data was reviewed and registered. Participants were randomly assigned to the intervention or control group through a lottery method. Patients were asked to not vary their usual care or initiate any other kind of therapy during the duration of the study. Post-Acute COVID symptoms At the time of the initial visit several clinical parameters were registered including: age, sex Body Mass Index (BMI), date of SARS-CoV-2 infection, admission into the Intensive Care Unit (yes/no), Visual Analogue Scale (VAS), and a large array of PACS-related symptoms(yes/no) that were classified according to the system/organ affected

Study design The study was designed as a prospective randomized controlled study. Data was collected at 3 time points: 1) initial visit (baseline), 2) at the end of BT or one month after baseline in control group, and 3) one month after BT finalization or two months after baseline in control group. Balneotherapy (BT) intervention The BT intervention consisted of 3 weekly sessions on alternate days in groups of 8 during 4 weeks, i.e., 12 sessions in total. The weekly planning was structured as following:

1 st day: Pool, shower, inhalation and aquatic exercise 2 nd day: Pool, shower, inhalation. 3 rd day: Pool, shower, inhalation and aquatic exercise The exercise program was designed by qualified specialists from the Caldes de Montbui spa. Exercises were performed in the thermal water pool, at 32°C during 2 hours. At the start of the session, patients were instructed to inhale thermal water vapor for 10 minutes, alternating between nose and mouth. Subsequently they underwent a circular shower during 10 minutes with a very fine jet that ran from the ankles to the neck to activate circulation. The temperature of the water and the power of the jet was set by the patient.

Next, they started the exercise program which lasted 15 minutes and was structured as follows:

  1. Ankle joints workout, knee flexions, and abductors workout.
  2. Waist and arm rotation.
  3. Arm raise exercises: arms were raised and lowered from legs to mid-waist. Subsequently, the same exercise was repeated but raising concomitantly knees and, if possible, clapping hands above the head.
  4. Hand exercises: patients were instructed to open and close their hands first, and then, repeated the same exercise but alternating hiding or exposing their thumbs.
  5. Lateral neck movements.
  6. Cycling and rowing movements while holding onto the pool's wall.
  7. Walking 2 laps around the pool. During the last 15-20 minutes patients were allowed to relax in the whirlpool.

Control group Patients from the control group were instructed to not participate in any BT-related activity during the duration of the study and to continue with usual care and activities.

Primary Outcome To evaluate the effects of BT we employed an array of validated self-reported questionnaires that covered an important part of PACS symptomatology. The primary outcome of the study was to evaluate differences in questionnaire scores from baseline between both groups. The following scales and questionnaires were employed:

  1. Post-COVID-19 functional status scale (PCFS)
  2. Modified Medical Research Council (mMRC) Dyspnoea Scale
  3. Short Form-36 Health Survey (SF-36) to evaluate generic health-related quality of life (HRQL)
  4. Pittsburgh Sleep Quality Index (PSQI)
  5. Hospital Anxiety and Depression Scale (HADS)
  6. Memory failures in everyday life following severe head injury (MFE-30)
  7. Visual Analogic Scale (VAS) Secondary outcomes The percentage of individuals within each group that showed any improvement in the questionnaires' scores at timepoints 2 and 3 compared to baseline were also calculated and compared between groups.

Statistical methods Descriptive statistics were used for demographic and clinical characteristics related to PACS. Comparisons between groups for quantitative variables were performed by t-test and chi-square tests were used for qualitative variables. Questionnaire scores were analysed using the intra-individual absolute change between baseline and post-BT or one month after baseline (control group), and between baseline and one month after completing BT or two months after baseline (control group). One-way ANOVA or chi-square were used for comparisons between groups. The change between time points was also categorized according to whether score improvement was observed (yes/no).

Chi-square test was used to perform the corresponding comparisons between groups.

Finally, univariate General Linear Model (GLM) or multinomial logistic regression were used for group comparisons adjusted by age and BMI. Statistical analysis was done with Statistical Package for the Social Sciences (SPSS) Statistics version 22.0. P values lower than 0.05 were considered significant.

Being tested
Balneotherapy and aquatic exercises
Keywords
Balneotherapy, Post-COVID-19 syndrome, Patient Reported Outcome Measures
Medical subject headings
Post-Acute COVID-19 Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Balneotherapy and aquatic exercisesOther

    Information has already been included in arm/group descriptions

Study groups in NCT05765591
Study groupRoleWhat they receive
Balneotherapy groupExperimentalThe patients allocated to the Balneotherapy group were subject to 3 weekly sessions of Balneotherapy together with an structured program of aquatic exercises on alternate days in groups of 8 during 4 weeks. The weekly planning was structured as following: 1. st day: Pool, shower, inhalation and aquatic exercises 2. nd day: Pool, shower, inhalation. 3. rd day: Pool, shower, inhalation and aquatic exercises
Receives: Other: Balneotherapy and aquatic exercises
Control groupNo interventionPatients from the control group were instructed to not participate in any BT-related activity during the duration of the study and to continue with usual care and activities

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Differences in questionnaire scores in follow-up time points compared to baseline between both groups

    To evaluate the effects of BT we employed an array of validated self-reported questionnaires that covered an important part of PACS symptomatology. The primary outcome of the study was to evaluate differences in questionnaire scores from baseline between both groups. The following scales and questionnaires were employed:

    1. Post-COVID-19 functional status scale (PCFS)
    2. mMRC (Modified Medical Research Council) Dyspnoea Scale
    3. Short Form-36 Health Survey (SF-36)
    4. Pittsburgh Sleep Quality Index (PSQI)
    5. Hospital Anxiety and Depression Scale (HADS)
    6. Memory failures in everyday life following severe head injury (MFE-30)
    7. Visual Analogic Scale (VAS)

    Measured: 2 months i.e., baseline, post-balneotherapy (or one month post-baseline in the control group), and 1 month post-balneotherapy (or 2 months post-baseline in the control group)

Secondary outcomes (1)
  1. Differences in the percentage of individuals within each group that showed any improvement in the questionnaires' scores at follow-up time-points compared to baseline

    Differences in the percentage of individuals within each group that showed any improvement in the questionnaires' scores at follow-up time-points compared to baseline. The following scales and questionnaires were employed:

    1. Post-COVID-19 functional status scale (PCFS)
    2. mMRC (Modified Medical Research Council) Dyspnoea Scale
    3. Short Form-36 Health Survey (SF-36)
    4. Pittsburgh Sleep Quality Index (PSQI)
    5. Hospital Anxiety and Depression Scale (HADS)
    6. Memory failures in everyday life following severe head injury (MFE-30)
    7. Visual Analogic Scale (VAS)

    Measured: 2 months i.e., baseline, post-balneotherapy (or one month post-baseline in the control group), and 1 month post-balneotherapy (or 2 months post-baseline in the control group)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Mar 2023
  2. Study start29 Mar 2022
  3. Primary completion29 Oct 2022
  4. Study completion31 Jan 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized controlled longitudinal interventional study
Masking
None (open label)
Enrolment
98 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05765591
Sponsor's protocol ID
2021/10072/I
Status last verified
Mar 2023
First submitted
9 Mar 2023
Last updated
13 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: This is a closed study and there is no plan to share individual participant data.

Publications

  • Ovejero D, Ribes A, Villar-Garcia J, Trenchs-Rodriguez M, Lopez D, Nogues X, Guerri-Fernandez R, Garcia-Giralt N. Balneotherapy for the treatment of post-COVID syndrome: a randomized controlled trial. BMC Complement Med Ther. 2025 Feb 4;25(1):37. doi: 10.1186/s12906-025-04784-3.

    PubMed 39905419

Questions about this trial

What is this clinical trial studying?

A study testing Balneotherapy and aquatic exercises in people with Post-COVID-19 Syndrome, run by Parc de Salut Mar at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Differences in questionnaire scores in follow-up time points compared to baseline between both groups (time frame: 2 months i.e., baseline, post-balneotherapy (or one month post-baseline in the control group), and 1 month post-balneotherapy (or 2 months post-baseline in the control group)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05765591, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in